glp 1 which company Ozempic Statistics: GLP-1 Weight Loss Medication Data Shortages improve for Lilly's GLP-1

As summarized by the American Journal of Managed Care: "Physicians have pointed out that no other chronic condition in Medicare is treated this way with an effective medication offered temporarily and then potentially withdrawn." For obesity, which is classified as a chronic condition by the American Medical Association and most major medical societies, offering 18 months of effective treatment with no guaranteed continuation is clinically unusual

Because this was an observational cohort study , it can identify an association between GLP-1 receptor agonists and NAION but cannot establish a direct cause-and-effect relationship

PMID: 27 CotaVSohrabiSKaletskyRMurphyCT

For me, the answer was GLP-1s, Williams said

Until more studies confirm safety, its best to avoid NAD boosters unless prescribed by a doctor

1, Introduction